GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Level Biotechnology Inc (ROCO:3118) » Definitions » E10

Level Biotechnology (ROCO:3118) E10 : NT$2.28 (As of Sep. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Level Biotechnology E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Level Biotechnology's adjusted earnings per share data for the three months ended in Sep. 2024 was NT$0.460. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is NT$2.28 for the trailing ten years ended in Sep. 2024.

During the past 12 months, Level Biotechnology's average E10 Growth Rate was -1.30% per year. During the past 3 years, the average E10 Growth Rate was 3.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Level Biotechnology was 3.80% per year. The lowest was 2.60% per year. And the median was 3.20% per year.

As of today (2024-12-11), Level Biotechnology's current stock price is NT$32.30. Level Biotechnology's E10 for the quarter that ended in Sep. 2024 was NT$2.28. Level Biotechnology's Shiller PE Ratio of today is 14.17.

During the past 13 years, the highest Shiller PE Ratio of Level Biotechnology was 18.32. The lowest was 10.43. And the median was 13.84.


Level Biotechnology E10 Historical Data

The historical data trend for Level Biotechnology's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Level Biotechnology E10 Chart

Level Biotechnology Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.09 2.03 2.15 2.26 2.27

Level Biotechnology Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.31 2.27 2.31 2.29 2.28

Competitive Comparison of Level Biotechnology's E10

For the Biotechnology subindustry, Level Biotechnology's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Level Biotechnology's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Level Biotechnology's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Level Biotechnology's Shiller PE Ratio falls into.



Level Biotechnology E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Level Biotechnology's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=0.46/133.0289*133.0289
=0.460

Current CPI (Sep. 2024) = 133.0289.

Level Biotechnology Quarterly Data

per share eps CPI Adj_EPS
201412 0.870 99.070 1.168
201503 0.480 99.621 0.641
201506 0.640 100.684 0.846
201509 0.620 100.392 0.822
201512 0.670 99.792 0.893
201603 0.470 100.470 0.622
201606 0.380 101.688 0.497
201609 0.340 101.861 0.444
201612 0.750 101.863 0.979
201703 0.540 102.862 0.698
201706 0.660 103.349 0.850
201709 0.270 104.136 0.345
201712 0.630 104.011 0.806
201803 0.180 105.290 0.227
201806 0.310 106.317 0.388
201809 0.300 106.507 0.375
201812 0.400 105.998 0.502
201903 0.240 107.251 0.298
201906 0.440 108.070 0.542
201909 0.360 108.329 0.442
201912 0.410 108.420 0.503
202003 0.240 108.902 0.293
202006 0.450 108.767 0.550
202009 0.440 109.815 0.533
202012 0.650 109.897 0.787
202103 0.560 111.754 0.667
202106 0.480 114.631 0.557
202109 0.570 115.734 0.655
202112 0.480 117.630 0.543
202203 0.340 121.301 0.373
202206 0.520 125.017 0.553
202209 0.410 125.227 0.436
202212 0.530 125.222 0.563
202303 0.500 127.348 0.522
202306 0.460 128.729 0.475
202309 0.350 129.860 0.359
202312 0.620 129.419 0.637
202403 0.590 131.776 0.596
202406 0.350 132.554 0.351
202409 0.460 133.029 0.460

Add all the adjusted EPS together and divide 10 will get our e10.


Level Biotechnology  (ROCO:3118) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Level Biotechnology's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=32.30/2.28
=14.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Level Biotechnology was 18.32. The lowest was 10.43. And the median was 13.84.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Level Biotechnology E10 Related Terms

Thank you for viewing the detailed overview of Level Biotechnology's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Level Biotechnology Business Description

Traded in Other Exchanges
N/A
Address
No.80, Lane 169, Kangning Street, Xizhi District, New Taipei City, TWN, 221
Level Biotechnology Inc is a Taiwan-based company engaged in the sales of biomedical products and providing preclinical testing services.

Level Biotechnology Headlines

No Headlines